Fresenius Medical Care is taking the next step in extracorporeal life support with Xenios 2.0

Fresenius Medical Care’s heart & lung business unit, Xenios AG, introduces the all-new Xenios 2.0. This system enables healthcare professionals to take the next step in extracorporeal life support (ECLS). […]

Weiterlesen

Neonatal and pediatric ECMO with MiniLung petite kit

Fresenius Medical Care’s heart & lung division Xenios AG introduced the MiniLung petite kit at ESICM LIVES congress this October. This patient kit was developed especially for neonatal and pediatric […]

Weiterlesen

Fresenius Medical Care Heart & Lung enables ECMO simulation in virtual reality

Fresenius Medical Care’s heart & lung division Xenios AG presents its virtual reality application at ESCIM LIVES congress in Paris. Visitors can discover a fictitious ECMO case and interactive hands-on […]

Weiterlesen

Novalung-System erhält Zulassung der US-FDA

Die US-FDA (Behörde für Lebens- und Arzneimittelsicherheit) hat Fresenius Medical Care Nordamerika und Xenios, ein Unternehmen von Fresenius Medical Care, die 510(k)-Zulassung für das Novalung-System für den Langzeiteinsatz bei Patienten […]

Weiterlesen